000937492 000__ 02600cam\a2200433Mu\4500
000937492 001__ 937492
000937492 005__ 20230306151835.0
000937492 006__ m\\\\\o\\d\\\\\\\\
000937492 007__ cr\cn\nnnunnun
000937492 008__ 200620s2020\\\\si\a\\\\o\\\\\000\0\eng\d
000937492 019__ $$a1159042609$$a1159169784$$a1178614740
000937492 020__ $$a9811527245
000937492 020__ $$a9789811527241$$q(electronic book)
000937492 020__ $$z9789811527234
000937492 020__ $$z9811527237
000937492 0247_ $$a10.1007/978-981-15-2724-1$$2doi
000937492 035__ $$aSP(OCoLC)on1159680803
000937492 035__ $$aSP(OCoLC)1159680803$$z(OCoLC)1159042609$$z(OCoLC)1159169784$$z(OCoLC)1178614740
000937492 040__ $$aDKDLA$$beng$$cDKDLA$$dOCLCO$$dOCLCF$$dEBLCP$$dN$T$$dYDX$$dGW5XE$$dUKMGB
000937492 049__ $$aISEA
000937492 050_4 $$aH1-970.9
000937492 08204 $$a362.17/82$$223
000937492 1001_ $$aBabar, Zaheer-ud-Din.
000937492 24510 $$aGlobal Pharmaceutical Policy /$$cedited by Zaheer-Ud-Din Babar
000937492 250__ $$a1. ed. 2020
000937492 264_1 $$aSingapore :$$bSpringer Singapore :$$bImprint: Palgrave Macmillan,$$c2020
000937492 300__ $$a1 online resource (xviiiI, 365 pages) :$$billustrations.
000937492 336__ $$atext$$btxt$$2rdacontent
000937492 337__ $$acomputer$$bc$$2rdamedia
000937492 338__ $$aonline resource$$bcr$$2rdacarrier
000937492 5050_ $$a1 Medicines Safety in the Gloablized Context -- 2 Managing the Pharmaceutical Supply Chain -- To Sustainability and Beyond -- 3 Generic Medicines and Biosimilars: Impact on Global Pharmaceutical Policy -- 4 Global Access to Cancer Medicines -- 5 Medicines Pricing: Limitations of Existing Policies and New Models -- 6 Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014-2019 -- 7 Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components -- 8 Access to Medicines: Case Studies from Lmics (Russia and Kyrgyzstan) -- 9 Access and Use of Medicines in Ukraine -- 10 Public Participation in Access to Medicines -- 11 Pharmaceutical Policy and Practice: A Review of Synthesis and Studies in China -- 12 Access to Vaccines and Immunization Programme -- 13. Global Antibiotics Use and Resistance -- 14 Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider
000937492 506__ $$aAccess limited to authorized users.
000937492 588__ $$aDescription based on print version record.
000937492 650_0 $$aPharmaceutical policy.
000937492 77608 $$iPrint version:$$aBabar, Zaheer-ud-Din$$tGlobal Pharmaceutical Policy$$dSingapore : Palgrave Macmillan US,c2020$$z9789811527234
000937492 852__ $$bebk
000937492 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-981-15-2724-1$$zOnline Access$$91397441.1
000937492 909CO $$ooai:library.usi.edu:937492$$pGLOBAL_SET
000937492 980__ $$aEBOOK
000937492 980__ $$aBIB
000937492 982__ $$aEbook
000937492 983__ $$aOnline
000937492 994__ $$a92$$bISE